The HALIX facility

Our state-of-the-art facility for the development and production of biopharmaceutical drug substances and drug products is operational in the Leiden Bio Science Park, the Netherlands since 2019. Designed in compliance to the latest GMP standards, HALIX produces biologics on four floors with 6,700 m2 development and production area.

State-of-the-art facility designed for GMP manufacturing

Equipped and designed for both clinical and commercial applications, the HALIX facility specializes in the production of viral products, proteins, and custom new technologies tailored to our clients’ needs. The building encompasses a state-of-the-art manufacturing line dedicated to virus and a protein production, capable of handling up to 1,000 L single-use bioreactor capacity.

Within the facility, lab spaces are optimized for process development, analytical development, and quality control. Furthermore, the third and fourth floors are reserved to offer additional capacity for future growth and to meet the long-term manufacturing requirements of our clients.

State-of-the-art facility designed for cGMP manufacturing

Equipped and designed for both clinical and commercial applications, the HALIX facility specializes in the production of viral products, proteins, and custom new technologies tailored to our clients’ needs. The building encompasses a state-of-the-art manufacturing line dedicated to virus and a distinct area for protein production, capable of handling up to 1,000 L single-use bioreactor capacity.

Within the facility, lab spaces are optimized for process development, analytical progression, and strict quality control. Furthermore, the third and fourth floors are reserved to offer additional capacity for future growth and to meet the long-term manufacturing requirements of our clients.

cGMP production services and capabilities

Our fully licensed production facility in the Netherlands allows for flexible and scalable contract development and cGMP production from preclinical to commercial scale products. Our production capabilities cover the whole manufacturing spectrum and include:

GMP recombinant protein manufacturing

We support you in developing and commercializing recombinant proteins and antibodies, enabling the treatment and prevention of life-threatening conditions.

GMP viral product manufacturing

We support you with the development & commercialization of viral products enabling the treatment and prevention of life threatening conditions.

Aseptic fill and finish and lyophilization

We provide GMP certified drug product production capabilities with a small and large scale filling line, processing over a million vials per year.

Development of small to large scale production processes

We bring your product into the clinical phase with our small scale production, analytical development, lyophilization cycle development and upscaling services.

GMP viral product manufacturing

We support you with the development & commercialization of viral products enabling the treatment and prevention of life threatening conditions.

GMP recombinant protein manufacturing

We support you in developing and commercializing recombinant proteins and antibodies, enabling the treatment and prevention of life-threatening conditions.

Aseptic fill and finish and lyophilization

We provide GMP certified drug product production capabilities with a small and large scale filling line, processing over a million vials per year.

Development of small to large scale production processes

We bring your product into the clinical phase with our small scale production, analytical development, lyophilization cycle development and upscaling services.